CDK3
Cyclin-dependent kinase 3
Also known as: CDK3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q00526
- Gene
- CDK3
- Ensembl
- ENSG00000250506
- Chromosome
- 17
- Canonical length
- 305 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the cyclin-dependent protein kinase family. The protein promotes entry into S phase, in part by activating members of the E2F family of transcription factors. The protein also associates with cyclin C and phosphorylates the retinoblastoma 1 protein to promote exit from G0. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
305 residues, UniProt reviewed canonical sequence.
>Q00526|CDK3
1 MDMFQKVEKI GEGTYGVVYK AKNRETGQLV ALKKIRLDLE MEGVPSTAIR EISLLKELKH
61 PNIVRLLDVV HNERKLYLVF EFLSQDLKKY MDSTPGSELP LHLIKSYLFQ LLQGVSFCHS
121 HRVIHRDLKP QNLLINELGA IKLADFGLAR AFGVPLRTYT HEVVTLWYRA PEILLGSKFY
181 TTAVDIWSIG CIFAEMVTRK ALFPGDSEID QLFRIFRMLG TPSEDTWPGV TQLPDYKGSF
241 PKWTRKGLEE IVPNLEPEGR DLLMQLLQYD PSQRITAKTA LAHPYFSSPE PSPAARQYVL
301 QRFRHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- liver: 34 nTPM
- prostate: 25 nTPM
- skin: 23 nTPM
- spleen: 21 nTPM
- pituitary gland: 19 nTPM
- thyroid gland: 19 nTPM
Single-cell type
- proximal tubule cells: 12 nCPM
- podocytes: 9.8 nCPM
- renal connecting tubule cells: 8 nCPM
- distal convoluted tubule cells: 7.5 nCPM
- astrocytes: 7 nCPM
- papillary tip epithelial cells: 6.7 nCPM
Immune cell
- T-reg: 0.4 nTPM
- naive CD4 T-cell: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- white matter: 8.1 nTPM
- cerebral cortex: 5.7 nTPM
- medulla oblongata: 5.1 nTPM
- hypothalamus: 5 nTPM
- choroid plexus: 4.9 nTPM
- pons: 4.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- cell population proliferation
- DNA damage response
- G0 to G1 transition
- G1/S transition of mitotic cell cycle
- negative regulation of Notch signaling pathway
- regulation of G2/M transition of mitotic cell cycle
- regulation of gene expression
- signal transduction
Molecular functions
- ATP binding
- cyclin binding
- cyclin-dependent protein serine/threonine kinase activity
- protein serine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDK3 as an antibody target. Whether an autoantibody or antibody against CDK3 could matter depends on whether native CDK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...